Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Welcome to Travere Therapeutics

Global Medical Affairs

At Travere Therapeutics Global Medical Affairs,
we are dedicated to sharing scientific knowledge, collaborating with experts,
and innovation for improved rare disease outcomes.

Publications IgAN Nephrology
Efficacy and Safety of Sparsentan Versus Irbesartan in Patients with IgA Nephopathy (PROTECT): 2-year Results From a Randomised Active-Controlled Phase 3 Trial

The Lancet
2023

Learn more